The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

Volkswagen will unveil the electric T-Cross at IAA Mobility, dubbed the ID.2X. CEO Thomas Schäfer confirmed the ...

With so many places to buy a used car, finding the best one can seem overwhelming. Knowing the pros and cons of each can help. Many, or all, of the products featured on this page are from our ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

According to the auto giant, the third-gen FC System is smaller, lighter, more dependable and more efficient than its predecessor. Toyota said the system is up to two times more durable than before ...

SOUTH SAN FRANCISCO - Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology firm specializing in allogeneic CAR T therapies currently valued at approximately $299 million, has published new data ...

WSU researchers have created HuT mice with human-like short telomeres, allowing for groundbreaking studies on aging, cancer, ...

Esse tipo de câncer atinge crianças, adultos e idosos; diagnóstico precoce aumenta as chances de sucesso do tratamento ...

Apesar das perguntas que seguem sem resposta, cientistas já fizeram enormes avanços na compreensão e no tratamento da doença ...